Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Lymphoma 32Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Leukemia 26Lymphoma, Non-Hodgkin 18Sarcoma 17Leukemia, Myeloid, Acute 16Hematologic Neoplasms 12Neuroblastoma 11Neoplasms 11Myelodysplastic Syndromes 11Hodgkin Disease 11Leukemia, Myelogenous, Chronic, BCR-ABL Positive 9Leukemia, Lymphocytic, Chronic, B-Cell 9Breast Neoplasms 9Burkitt Lymphoma 8Osteosarcoma 6Multiple Myeloma 6Lymphoma, Large B-Cell, Diffuse 6Melanoma 5Lymphoma, Mantle-Cell 5Lymphoma, Follicular 5Rhabdoid Tumor 4Retinoblastoma 4Recurrence 4Neuroectodermal Tumors, Primitive, Peripheral 4Myeloproliferative Disorders 4Medulloblastoma 4Leukemia, Biphenotypic, Acute 4Leukemia, B-Cell 4Hematologic Diseases 4

Interventions

Dexamethasone 51Aprepitant 39Palonosetron 37Ondansetron 31Granisetron 22Calcium Dobesilate 14fosaprepitant 13Olanzapine 13Therapeutics 8dexamethasone acetate 7ramosetron 6netupitant, palosentron drug combination 6casopitant 6Tropisetron 6Cyclophosphamide 6dexamethasone 21-phosphate 5Radiotherapy 5Metoclopramide 5Doxorubicin 5netupitant 4dolasetron 4Surveys and Questionnaires 4Dronabinol 4Acupressure 4Yoga 3Vincristine 3Tablets 3Psychiatric Rehabilitation 3Prochlorperazine 3Lorazepam 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Vomiting × Mesna × Clear all
NCT01490060 2016-04-11

Fosaprepitant in Patients Receiving Ifosfamide-based Regimen

M.D. Anderson Cancer Center

Phase NA Completed
47 enrolled 6 charts
Sarcoma

Nausea, Neoplasms, Sarcoma, Vomiting

NCT00410488 2013-03-22

Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI)

M.D. Anderson Cancer Center

Phase NA Completed
51 enrolled 5 charts
Sarcoma

Nausea, Sarcoma, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡